dasatinib senolytic
Selected indexed studies
- Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. (Aging Cell, 2023) [PMID:36637079]
- Senolytic drugs: from discovery to translation. (J Intern Med, 2020) [PMID:32686219]
- Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. (Nat Commun, 2021) [PMID:34480023]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fisetin is a senotherapeutic that extends health and lifespan. (2018) pubmed
- Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. (2023) pubmed
- Senolytic drugs: from discovery to translation. (2020) pubmed
- Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. (2021) pubmed
- Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease. (2024) pubmed
- Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps. (2025) pubmed
- Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice. (2025) pubmed
- The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. (2015) pubmed
- Senolytics improve physical function and increase lifespan in old age. (2018) pubmed
- Antidiabetic Effects of the Senolytic Agent Dasatinib. (2021) pubmed